Nunes, M.A.; Toricelli, M.; Schöwe, N.M.; Malerba, H.N.; Dong-Creste, K.E.; Farah, D.M.A.T.; De Angelis, K.; Irigoyen, M.C.; Gobeil, F.; Araujo Viel, T.;
et al. Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer’s Disease Pathological Characteristics in a Transgenic Mouse Model. Pharmaceuticals 2020, 13, 288.
https://doi.org/10.3390/ph13100288
AMA Style
Nunes MA, Toricelli M, Schöwe NM, Malerba HN, Dong-Creste KE, Farah DMAT, De Angelis K, Irigoyen MC, Gobeil F, Araujo Viel T,
et al. Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer’s Disease Pathological Characteristics in a Transgenic Mouse Model. Pharmaceuticals. 2020; 13(10):288.
https://doi.org/10.3390/ph13100288
Chicago/Turabian Style
Nunes, Marielza Andrade, Mariana Toricelli, Natalia Mendes Schöwe, Helena Nascimento Malerba, Karis Ester Dong-Creste, Daniela Moura Azevedo Tuma Farah, Katia De Angelis, Maria Claudia Irigoyen, Fernand Gobeil, Tânia Araujo Viel,
and et al. 2020. "Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer’s Disease Pathological Characteristics in a Transgenic Mouse Model" Pharmaceuticals 13, no. 10: 288.
https://doi.org/10.3390/ph13100288
APA Style
Nunes, M. A., Toricelli, M., Schöwe, N. M., Malerba, H. N., Dong-Creste, K. E., Farah, D. M. A. T., De Angelis, K., Irigoyen, M. C., Gobeil, F., Araujo Viel, T., & Buck, H. S.
(2020). Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer’s Disease Pathological Characteristics in a Transgenic Mouse Model. Pharmaceuticals, 13(10), 288.
https://doi.org/10.3390/ph13100288
